FORT LEE, N.J., Feb. 14, 2013 - Herborium Group, Inc., (OTC Pink: HBRM) www.herborium.com, a Botanical Therapeutics® Company has announced today that it has completed the manufacturing of its unique, all herbal Sexual Enhancement Products Lasting Pleasure® for women and Lasting Power® for men. After the products are packaged using a very attractive and unique, environmentally sustainable European package design they are both expected to hit the market in March 2013.
Lasting Pleasure® and Lasting Power® represent over $1.5 billion market potential for natural sexual health products and has already been featured in November 2012,USA Today, Sexual Health Issue: "Healthy Relationships."
In addition, there is a growing need for women's sexual health products. The female sexual enhancement industry is poised for an explosion and is expected to grow into a multibillion dollar business as women themselves become increasingly aware of their sexuality and their sexual health. In 2012 the sales of female personal lubricants grew 41%. There is no Viagra comparative product on the market for women and Herborium's Lasting Pleasure® for Women is the ONLY product of its kind.
"We are extremely excited to be preparing an immediate roll-out of our sexual health products and we cannot find a better day to announce it - than a Valentine's Day." Commented Dr. Agnes P. Olszewski , Chairwoman & CEO of Herborium. "Herborium's sexual enhancement products' trajectory is for long term growth and it is also supported by its association with Kamasutra™ Spirit of Seduction – an innovative adult beverage developed with an unique herbal formula invented by Herborium. Kamasutra™ social media presence, www.kamasutraspirit.com and each bottle of Kamasutra™ product include references to Herborium's sexual health products. This represents a measurable value and most advantageous marketing opportunities for Lasting Pleasure® and Lasting Power®," concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visit www.herborium.com, www.herboriumsh.com, and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.